Jonas Göran Ekblom
Director/Board Member bij COMBIGENE AB
Profiel
Jonas Göran Ekblom is a businessperson who founded Anaborex, Inc. and who has been at the head of 6 different companies.
Presently, Dr. Ekblom occupies the position of President & Chief Executive Officer of Promore Pharma AB, President for Edge of The World Strategies Corp.
and Chairman for EffRx Pharmaceuticals SA. He is also on the board of Pergamum AB (former Chief Executive Officer), CombiGene AB, World 5 Ventures and Pergasus AB and Associate Professor at the University of Uppsala.
In his past career he occupied the position of Chairman of Axelar AB, Chief Executive Officer of BOWS Pharmaceuticals AG, Chief Operating Officer of Nanostream, Inc., Principal at Pharmacia AB, Principal at Biovitrum AB, Principal at Invitrogen AB, Principal at Sequenom GmbH and Director at Anaborex, Inc.
Dr. Ekblom received an undergraduate degree from the University of Stockholm, a doctorate from the University of Uppsala and a doctorate from USC School of Pharmacy.
Actieve functies van Jonas Göran Ekblom
Bedrijven | Functie | Begin |
---|---|---|
COMBIGENE AB | Director/Board Member | 01-01-2020 |
Edge of The World Strategies Corp. | President | 01-01-2007 |
World 5 Ventures | Director/Board Member | 01-01-2020 |
EffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Chairman | 01-01-2016 |
University of Uppsala | Corporate Officer/Principal | - |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Director/Board Member | 01-01-2015 |
Pergasus AB | Director/Board Member | - |
Eerdere bekende functies van Jonas Göran Ekblom
Bedrijven | Functie | Einde |
---|---|---|
Axelar AB
Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Chairman | 01-01-2019 |
The Releef Initiative | Director/Board Member | 01-01-2018 |
░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Jonas Göran Ekblom
University of Uppsala | Doctorate Degree |
University of Stockholm | Undergraduate Degree |
USC School of Pharmacy | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
COMBIGENE AB | Health Technology |
Bedrijven in privébezit | 16 |
---|---|
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA | Health Services |
EffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Health Technology |
Pharmacia AB | Health Technology |
Nanostream, Inc.
Nanostream, Inc. BiotechnologyHealth Technology Nanostream, Inc. provides microfluidic analytical systems. The company develops microfluidic systems to automate routine laboratory procedures that are critical to research productivity. It furnishes the miniaturized plumbing critical to the future of pharmaceutical sciences. Nanostream was founded in 1999 and is headquartered in Pasadena, CA. | Health Technology |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Axelar AB
Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Health Technology |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Health Technology |
Invitrogen AB | |
BOWS Pharmaceuticals AG
BOWS Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services BOWS Pharmaceuticals AG operates as a biotechnology firm. The company is headquartered in Zug, Switzerland. | Commercial Services |
Sequenom GmbH
Sequenom GmbH Medical SpecialtiesHealth Technology Part of Laboratory Corp. of America Holdings, Sequenom GmbH is a German company that manufactures computer applications and technology systems for the diagnostic of genomic sciences. The private company is based in Hamburg, Germany. | Health Technology |
The Releef Initiative | |
World 5 Ventures | |
Edge of The World Strategies Corp. | |
Pergasus AB |